Skip to content

Dolby Laboratories

US · DLB #2013 by market cap Listed 1970
55.33 +0.56 +1.02%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 56.00 +2.25%
After-hours 55.33 0.00%
66.1248.2355.332026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on DLB?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -13.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 6.4% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 20.5x Better than 41%
Forward P/E 21.0x Better than 34%
Price / Sales 4.4x Better than 26%
P/E vs own 5-yr range 25th pctl Better than 81%
Growth B

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 2.5% Better than 36%
Net income CAGR (3Y) 11.5% Better than 62%
Free cash flow CAGR (3Y) 18.4% Better than 62%
Profitability A-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 88.1% Better than 95%
Operating margin 20.8% Better than 78%
Net margin 18.9% Better than 78%
Return on equity 10.0% Better than 52%
Return on invested capital 9.8% Better than 68%
Momentum C+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -15.2% Better than 39%
6-month return 1.7% Better than 59%
12-month return (ex latest month) -4.7% Better than 28%
Distance below 52-week high 19.9% Better than 60%
Financial Health A+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.2x Better than 75%
Debt to assets 1.2% Better than 91%
Interest coverage 547.4x Better than 97%
Free cash flow / net income 168.7% Better than 71%
Analyst View A-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 58.1% Better than 71%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -13.02%
1M -11.20%
3M -13.80%
6M +2.83%
YTD -12.32%
1Y -13.58%
3Y -30.15%
5Y -33.00%

Key statistics

Price & volume

Prev close
54.77
Open
54.75
Day range
54.39 - 58.10
Avg price
55.81
Volume
1.35M
Turnover
75.12M
Amplitude
6.77%
52-week range
47.98 - 69.11

Valuation

P/E
20.49
P/E (TTM)
20.49
P/B
1.97
EPS
2.70
Net profit
250.35M
Net assets
2.60B

Share structure

Market cap
5.13B
Float cap
3.20B
Shares out
92.72M
Float shares
57.82M

Dividend & listing

Dividend (TTM)
1.44
Listing date
1970-01-01
52-week range 35% of range
47.98 69.11

19.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-10.53M net over the window

Short interest

Shares short
6.01M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Dolby Laboratories (DLB)?

Dolby Laboratories last traded at 55.33. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Dolby Laboratories's market cap?

About 5.13B.

What is the P/E ratio of Dolby Laboratories?

The trailing twelve-month P/E is 20.49, below its own 5-year average of 32.90 — toward the bottom of its historical range (24.96% percentile). See the Valuation tab for the full history.

Does Dolby Laboratories pay a dividend?

Yes. The trailing dividend yield is 2.60%. The 2025 payout was up 9.8% from 2024. See the Dividends tab for the full payment history.

Is Dolby Laboratories a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 87.50, which implies 58.1% upside from the current price. This is not investment advice.

What is Dolby Laboratories's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Dolby Laboratories a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Dolby Laboratories discussion 0 comments

Add a comment